| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.23 | 0.005 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.2 | 0.006 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |